Literature DB >> 14470743

Heparin potassium in the treatment of chronic multiple sclerosis.

J MASCHMEYER, R SHEARER, E LONSER, D K SPINDLE.   

Abstract

Entities:  

Keywords:  HEPARIN/therapy; MULTIPLE SCLEROSIS/therapy

Mesh：

Substances：

Year:  1961        PMID： 14470743

Source DB:  PubMed          Journal:  Bull Los Angel Neuro Soc        ISSN： 1040-5925


× No keyword cloud information.
  4 in total

1.  Thrombin mutant W215A/E217A treatment improves neurological outcome and attenuates central nervous system damage in experimental autoimmune encephalomyelitis.

Authors:  Norah G Verbout; Xiaolin Yu; Laura D Healy; Kevin G Phillips; Erik I Tucker; András Gruber; Owen J T McCarty; Halina Offner
Journal:  Metab Brain Dis       Date:  2014-05-09       Impact factor: 3.584

Review 2.  Thrombin generation and activity in multiple sclerosis.

Authors:  Kelley R Jordan; Ivan Parra-Izquierdo; András Gruber; Joseph J Shatzel; Peter Pham; Larry S Sherman; Owen J T McCarty; Norah G Verbout
Journal:  Metab Brain Dis       Date:  2021-01-07       Impact factor: 3.584

3.  Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis.

Authors:  Leonie Stolz; Amin Derouiche; Kavi Devraj; Frank Weber; Robert Brunkhorst; Christian Foerch
Journal:  J Neuroinflammation       Date:  2017-07-28       Impact factor: 8.322

Review 4.  Thrombotic processes in multiple sclerosis as manifestation of innate immune activation.

Authors:  Tatiana Koudriavtseva
Journal:  Front Neurol       Date:  2014-07-07       Impact factor: 4.003
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.